ArticleMolecules (Basel, Switzerland)2009
Antimicrobial activity of some thiourea derivatives and their nickel and copper complexes.
Article in Molecules (Basel, Switzerland), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Chemical profiling and evaluation of in vitro antibacterial and antibiotic synergistic activities of Cleistanthus bracteosus Jabl. from Malaysian rainforests.BMC complementary medicine and therapies · 2026Article
- Novel xanthan gum hydrogels boosted with crosslinked carboxymethyl chitosan and zinc oxide nanoparticles: synthesis, characterization and biological activity evaluation.BMC chemistry · 2025Article
- Boronic Derivatives of Thiosemicarbazones as Tyrosinase Inhibitors.Pharmaceutics · 2025Article
- Antifungal and Antioxidant Activity of Thiourea Derivatives Against NosocomialMolecules (Basel, Switzerland) · 2025Article
- Article
- New N-acyl Thiourea Derivatives: Synthesis, Standardized Quantification Method and In Vitro Evaluation of Potential Biological Activities.Antibiotics (Basel, Switzerland) · 2023Article
- Antimicrobial Activities of Chitosan Derivatives.Pharmaceutics · 2021Article
- Investigation of the reactivity properties of a thiourea derivative with anticancer activity by DFT and MD simulations.Journal of molecular modeling · 2021Article
- Monosubstituted Acetophenone Thiosemicarbazones as Potent Inhibitors of Tyrosinase: Synthesis, Inhibitory Studies, and Molecular Docking.Pharmaceuticals (Basel, Switzerland) · 2021Article
- The Use of Copper as an Antimicrobial Agent in Health Care, Including Obstetrics and Gynecology.Clinical microbiology reviews · 2019Review
- Thiosemicarbazones with tyrosinase inhibitory activity.MedChemComm · 2019Review
- cis-Bromido(methyl-amine)-bis-(propane-1,3-di-amine)-cobalt(III) dibromide.Acta crystallographica. Section E, Structure reports online · 2013Article
- Di-aqua-dichlorido-bis-(pyridine-κN)cobalt(II).Acta crystallographica. Section E, Structure reports online · 2013Article
- cis-Bis[N'-(4-bromo-benzo-yl)-N,N-dimethyl-thio-ureato-κO,S]copper(II).Acta crystallographica. Section E, Structure reports online · 2011Article
- Hexa-kis-(thio-urea-κS)nickel(II) nitrate: a redetermination.Acta crystallographica. Section E, Structure reports online · 2010Article
- Chloridobis(ethane-1,2-diamine)(4-methyl-aniline)cobalt(III) dichloride monohydrate.Acta crystallographica. Section E, Structure reports online · 2009Article
- Ultrasound promoted synthesis of bis(substituted pyrazol-4-ylcarbonyl)-substituted thioureas.Molecules (Basel, Switzerland) · 2009Article
- Synthesis and characterization of N-(Arylcarbamothioyl)-cyclohexanecarboxamide derivatives: the crystal structure of N-(naphthalen-1-ylcarbamothioyl)cyclohexanecarboxamide.Molecules (Basel, Switzerland) · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Five thiourea derivative ligands and their Ni(2+) and Cu(2+) complexes have been synthesized. The compounds were screened for their in vitro anti-bacterial activity using Gram-positive bacteria (two different standard strains of Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Streptococcus pyogenes, Bacillus cereus) and Gram-negative bacteria (Esherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, Proteus vulgaris, Enterobacter aerogenes) and in vitro anti-yeast activity (Candida albicans, Candida krusei, Candida glabrata, Candida tropicalis, Candida parapsilosis). The minimum inhibitory concentration was determined for all ligands and their complexes. In vitro anti-yeast activity of both ligands and their metal complexes is greater than their in vitro anti-bacterial activity. The effect of the structure of the investigated compounds on the antimicrobial activity is discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.